JP2021518431A5 - - Google Patents
Info
- Publication number
- JP2021518431A5 JP2021518431A5 JP2020573085A JP2020573085A JP2021518431A5 JP 2021518431 A5 JP2021518431 A5 JP 2021518431A5 JP 2020573085 A JP2020573085 A JP 2020573085A JP 2020573085 A JP2020573085 A JP 2020573085A JP 2021518431 A5 JP2021518431 A5 JP 2021518431A5
- Authority
- JP
- Japan
- Prior art keywords
- constipation
- dgat1
- pharmaceutical composition
- inhibitor
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862644033P | 2018-03-16 | 2018-03-16 | |
| US62/644,033 | 2018-03-16 | ||
| PCT/US2019/022499 WO2019178492A1 (en) | 2018-03-16 | 2019-03-15 | Compositions and methods for treating severe constipation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518431A JP2021518431A (ja) | 2021-08-02 |
| JP2021518431A5 true JP2021518431A5 (cg-RX-API-DMAC7.html) | 2022-02-21 |
| JP7527984B2 JP7527984B2 (ja) | 2024-08-05 |
Family
ID=67904819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573085A Active JP7527984B2 (ja) | 2018-03-16 | 2019-03-15 | 重度の便秘を治療するための組成物及び方法 |
Country Status (24)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20210158A1 (es) | 2018-03-16 | 2021-01-26 | Anji Pharmaceuticals Inc | Composiciones y metodos para tratar el estrenimiento grave |
| KR102989262B1 (ko) | 2020-10-21 | 2026-07-08 | 주식회사 엘지에너지솔루션 | 전극 탭 고정부를 포함하는 용접장치 및 이를 이용한 전극 탭 용접 방법 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3225997A (en) | 1996-05-30 | 1998-01-05 | Trustees Of Columbia University In The City Of New York, The | Dna encoding acylcoenzyme a: cholesterol acyltransferase and uses thereof |
| US20030167483A1 (en) | 1998-06-24 | 2003-09-04 | Farese Robert V. | Diacylglycerol O-acyltransferase |
| CA2330363C (en) | 1998-06-24 | 2009-10-20 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
| US6344548B1 (en) | 1998-06-24 | 2002-02-05 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
| US20030154504A1 (en) | 1998-06-24 | 2003-08-14 | Farese Robert V. | Methods and compositions for modulating carbohydrate metabolism |
| US6100077A (en) | 1998-10-01 | 2000-08-08 | The Trustees Of Columbia University In The City Of New York | Isolation of a gene encoding diacylglycerol acyltransferase |
| WO2002002551A1 (en) | 2000-06-30 | 2002-01-10 | Sugen, Inc. | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| US6444427B1 (en) | 2000-07-11 | 2002-09-03 | The Regents Of The University Of California | Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof |
| JP4164645B2 (ja) | 2002-08-09 | 2008-10-15 | 株式会社大塚製薬工場 | Dgat阻害剤 |
| EP1562956A4 (en) | 2002-11-22 | 2007-10-10 | Japan Tobacco Inc | HETEROCYCLES CONTAINING FUSED BICYCLIC NITROGEN |
| US20040185559A1 (en) | 2003-03-21 | 2004-09-23 | Isis Pharmaceuticals Inc. | Modulation of diacylglycerol acyltransferase 1 expression |
| AR044152A1 (es) | 2003-05-09 | 2005-08-24 | Bayer Corp | Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad |
| WO2005013907A2 (en) | 2003-08-07 | 2005-02-17 | Japan Tobacco Inc. | Pyrrolo[1,2-b]pyridazine derivatives |
| GB0325192D0 (en) | 2003-10-29 | 2003-12-03 | Astrazeneca Ab | Method of use |
| JP2005206492A (ja) | 2004-01-21 | 2005-08-04 | Sankyo Co Ltd | スルホンアミド化合物 |
| AU2005209115A1 (en) | 2004-01-30 | 2005-08-11 | Japan Tobacco Inc. | Anorectic compounds |
| CA2572874A1 (en) | 2004-07-02 | 2006-01-12 | Sankyo Company Limited | Urea derivative |
| JP2006045209A (ja) | 2004-07-02 | 2006-02-16 | Sankyo Co Ltd | ウレア誘導体 |
| WO2006019020A1 (ja) | 2004-08-16 | 2006-02-23 | Sankyo Company, Limited | 置換されたウレア化合物 |
| AU2005295453A1 (en) | 2004-10-15 | 2006-04-27 | Bayer Healthcare Llc | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| BRPI0519058A2 (pt) | 2004-12-14 | 2008-12-23 | Astrazeneca Ab | composto ou um sal prà-droga farmaceuticamente aceitÁvel do mesmo, mÉtodos para produzir uma inibiÇço da atividade de dgat1 e para tratar diabete melito e/ou obesidade em um animal de sangue quente, uso de um composto, composiÇço farmacÊutica, e, processo para preparar um composto |
| MX2007013049A (es) | 2005-04-19 | 2008-01-11 | Bayer Pharmaceuticals Corp | Preparacion y uso de derivados de aril alquil acido para el tratamiento de la obesidad. |
| WO2007002740A2 (en) | 2005-06-28 | 2007-01-04 | E. I. Du Pont De Nemours And Company | Buffer compositions |
| PT2402319T (pt) * | 2006-03-31 | 2017-12-11 | Novartis Ag | Inibidores de dgat |
| GB0611506D0 (en) | 2006-06-10 | 2006-07-19 | Astrazeneca Ab | Chemical compounds |
| JO2972B1 (en) * | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| AR066169A1 (es) | 2007-09-28 | 2009-07-29 | Novartis Ag | Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat |
| WO2009112445A1 (en) * | 2008-03-10 | 2009-09-17 | Novartis Ag | Method of increasing cellular phosphatidyl choline by dgat1 inhibition |
| US8324241B2 (en) | 2008-04-11 | 2012-12-04 | Bristol-Myers Squibb Company | Triazolo compounds useful as DGAT1 inhibitors |
| SG183529A1 (en) * | 2010-03-30 | 2012-10-30 | Novartis Ag | Uses of dgat1 inhibitors |
| JP5841994B2 (ja) * | 2010-04-08 | 2016-01-13 | メディシノヴァ, インコーポレイテッド. | 過敏性腸症候群の処置方法及びその治療用組成物 |
| AR083417A1 (es) * | 2010-10-14 | 2013-02-21 | Novartis Ag | Composiciones farmaceuticas que contienen un dgat1 inhibidor |
| WO2013130370A2 (en) * | 2012-03-01 | 2013-09-06 | Merck Sharp & Dohme Corp. | Compounds as dgat-1 inhibitors |
| WO2013169648A1 (en) * | 2012-05-07 | 2013-11-14 | Novartis Ag | Pharmaceutical combinations comprising a dgat1 inhibtor and a triglyceride lowering drug |
| BR112015004165A2 (pt) * | 2012-08-29 | 2017-07-04 | Salix Pharmaceuticals Inc | métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas |
| CA2932873A1 (en) * | 2014-01-09 | 2015-07-16 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
| PE20210158A1 (es) | 2018-03-16 | 2021-01-26 | Anji Pharmaceuticals Inc | Composiciones y metodos para tratar el estrenimiento grave |
-
2019
- 2019-03-15 PE PE2020001407A patent/PE20210158A1/es unknown
- 2019-03-15 MX MX2020009604A patent/MX2020009604A/es unknown
- 2019-03-15 EP EP19767984.8A patent/EP3765012B1/en active Active
- 2019-03-15 AU AU2019234956A patent/AU2019234956B2/en active Active
- 2019-03-15 EA EA202092190A patent/EA202092190A1/ru unknown
- 2019-03-15 HR HRP20260544TT patent/HRP20260544T1/hr unknown
- 2019-03-15 SI SI201931051T patent/SI3765012T1/sl unknown
- 2019-03-15 PL PL19767984.8T patent/PL3765012T3/pl unknown
- 2019-03-15 KR KR1020207029661A patent/KR102747096B1/ko active Active
- 2019-03-15 BR BR112020018790-9A patent/BR112020018790A2/pt active IP Right Grant
- 2019-03-15 FI FIEP19767984.8T patent/FI3765012T3/fi active
- 2019-03-15 SG SG11202008971VA patent/SG11202008971VA/en unknown
- 2019-03-15 JP JP2020573085A patent/JP7527984B2/ja active Active
- 2019-03-15 WO PCT/US2019/022499 patent/WO2019178492A1/en not_active Ceased
- 2019-03-15 IL IL277332A patent/IL277332B2/en unknown
- 2019-03-15 CN CN201980019537.3A patent/CN111936137B/zh active Active
- 2019-03-15 MY MYPI2020004779A patent/MY205335A/en unknown
- 2019-03-15 DK DK19767984.8T patent/DK3765012T3/da active
- 2019-03-15 US US16/355,085 patent/US11224590B2/en active Active
- 2019-03-15 LT LTEPPCT/US2019/022499T patent/LT3765012T/lt unknown
- 2019-03-15 ES ES19767984T patent/ES3069001T3/es active Active
- 2019-03-15 PT PT197679848T patent/PT3765012T/pt unknown
- 2019-03-18 TW TW108109164A patent/TWI704917B/zh active
-
2020
- 2020-09-14 PH PH12020551468A patent/PH12020551468A1/en unknown
-
2021
- 2021-12-30 US US17/565,584 patent/US11819495B2/en active Active
-
2023
- 2023-10-11 US US18/378,976 patent/US12343334B2/en active Active
-
2025
- 2025-06-10 US US19/233,154 patent/US20260000651A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pandit et al. | Current updates on oxazolidinone and its significance | |
| US20060106039A1 (en) | Combinations | |
| JP2017505293A5 (cg-RX-API-DMAC7.html) | ||
| JP5786034B2 (ja) | 脂質異常症の治療に適したヘテロ環式化合物 | |
| WO2003028730A2 (en) | Pharmaceutical combinations of pde-v inhibitors and other agents | |
| JP2007016035A5 (cg-RX-API-DMAC7.html) | ||
| WO2000075113A1 (en) | Novel heterocyclic carboxamide derivatives | |
| JP7098214B2 (ja) | 非アルコール性脂肪性肝炎(NASH)の処置のためのsGC刺激物質の使用 | |
| TW200827344A (en) | Administration of dipeptidyl peptidase inhibitors | |
| JP2013521286A5 (cg-RX-API-DMAC7.html) | ||
| KR20130036093A (ko) | 화합물 및 방법 | |
| JP2010519216A (ja) | Ccr5拮抗薬のための医薬組成物および方法 | |
| JP2010505906A5 (cg-RX-API-DMAC7.html) | ||
| JP2009515887A5 (cg-RX-API-DMAC7.html) | ||
| JP2010516701A5 (cg-RX-API-DMAC7.html) | ||
| EP1487424B1 (en) | 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases | |
| WO2012161518A3 (ko) | RORα의 활성자로서의 신규한 thiourea 유도체 및 이를 함유하는 약학적 조성물 | |
| US20070299047A1 (en) | Combination of Organic Compounds | |
| NZ590177A (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
| NZ590315A (en) | Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof | |
| CN104039151A (zh) | 治疗中枢神经系统中小神经胶质细胞介导的神经元缺失的组织蛋白酶抑制剂 | |
| US20090018169A1 (en) | Sulfonamide Derivatives for the Treatment of Bacterial Infections | |
| JP2012505225A5 (cg-RX-API-DMAC7.html) | ||
| IL277332B1 (en) | Compositions and methods for treating severe constipation | |
| CN102143745A (zh) | 用于治疗胃肠道的炎性病况的噁唑烷酮 |